Preprocedural statin therapy, inflammation, and myocardial injury in low-risk stable coronary artery disease patients submitted to coronary stent implantation

2015 ◽  
Vol 87 (2) ◽  
pp. 222-229 ◽  
Author(s):  
Gilmar V. Greque ◽  
Carlos V. Serrano ◽  
Célia M. Strunz ◽  
Alexandre Soeiro ◽  
Márcio Santos ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Statin Therapy ◽  
Stent Implantation ◽  
Myocardial Injury ◽  
Stable Coronary Artery Disease ◽  
Coronary Stent ◽  
Low Risk ◽  
Coronary Stent Implantation ◽  
Artery Disease

Long-Term Follow-up After Coronary Stent Implantation in Patients with Coronary Artery Disease

Angiology ◽  
2002 ◽  
Vol 53 (2) ◽  
pp. 149-156 ◽  
Author(s):  
Hisataka Sasao ◽  
Akita Endo ◽  
Tohru Hasegawa ◽  
Yoshihiko Ichikawa ◽  
Ryosuke Noda ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Stent Implantation ◽  
Coronary Stent ◽  
Coronary Stent Implantation ◽  
Long Term Follow Up ◽  
Artery Disease

scholarly journals Long-Term Outcome of First-Generation Metallic Coronary Stent Implantation in Patients With Coronary Artery Disease

2007 ◽  
Vol 71 (9) ◽  
pp. 1360-1365 ◽  
Author(s):  
Noriyuki Fujii ◽  
Ryuta Asano ◽  
Masatoshi Nagayama ◽  
Tetsuya Tobaru ◽  
Kazuhiko Misu ◽  
...  
Keyword(s):  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Stent Implantation ◽  
First Generation ◽  
Coronary Stent ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Coronary Stent Implantation ◽  
Artery Disease

scholarly journals Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease

Thrombosis ◽  
2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Karl Mischke ◽  
Christian Knackstedt ◽  
Nikolaus Marx
Keyword(s):  
Atrial Fibrillation ◽  
Coronary Artery Disease ◽  
Coronary Artery ◽  
Antiplatelet Therapy ◽  
Oral Anticoagulation ◽  
Stent Implantation ◽  
Coronary Stent ◽  
Risk Scores ◽  
Coronary Stent Implantation ◽  
Artery Disease

Anticoagulation represents the mainstay of therapy for most patients with atrial fibrillation. Patients on oral anticoagulation often require concomitant antiplatelet therapy, mostly because of coronary artery disease. After coronary stent implantation, dual antiplatelet therapy is necessary. However, the combination of oral anticoagulation and antiplatelet therapy increases the bleeding risk. Risk scores such as the CHA2DS2-Vasc score and the HAS-BLED score help to identify both bleeding and stroke risk in individual patients. The guidelines of the European Society of Cardiology provide a rather detailed recommendation for patients on oral anticoagulation after coronary stent implantation. However, robust evidence is lacking for some of the recommendations, and especially for new oral anticoagulants and new antiplatelets few or no data are available. This review addresses some of the critical points of the guidelines and discusses potential advantages of new anticoagulants in patients with atrial fibrillation after stent implantation.

Sign in / Sign up

Export Citation Format

Share Document